99%以上のリード単位精度を取得するQ20+ケミストリ
V14とR10.4.1ポアを組み合わせたキットにより最高の精度を実現 • デュプレックス法によりQ30以上の精度を実現 • 収量、速度、マルチプレックスなどの点で最適なソリューションUnderstanding the drivers of oncogenesis
This case study highlights how a wide range of tumour-specific variation that can be captured within a single nanopore sequencing assay — from complex structural variants to epigenetic modifications.Oxford Nanopore technology update
Hear about the latest technology performance and innovations in the pipeline.Accelerating cancer research through comprehensive genomic analysis
Learn how nanopore technology can accurately resolve complex structural variants to provide new insight into the mechanisms of health and disease.Oxford Nanopore at ASHG 2023
Join us for on-booth product demonstrations, Data for Breakfast, and our Industry Education Session which will showcase how nanopore technology can resolve even the most complex genetic variation.Workflow: Tumour-normal
Here we present an end-to-end workflow to detect somatic variation between tumour-normal paired research samples.NCM 2023 Houston: buy 3 tickets, get 1 free
If you're looking to attend the Nanopore Community Meeting with colleagues you can now purchase three tickets and get one ticket free.- “This was almost a year of clinical testing, and it took about 24 hours to figure this out in our lab.”Danny Miller(米国のワシントン大学)
Accelerating cancer research through comprehensive genomic analysis
Discover the unique attributes of nanopore sequencing that are enabling researchers to characterise cancer at unprecedented resolution, unlocking previously hidden variation and accelerating research.- “…structural variant calls were highly accurate and complete, showing improvement over the current short-read and long-read methods.”Mikhail Kolmogorov et al., NIH
99%以上のリード単位精度を取得するQ20+ケミストリ
V14とR10.4.1ポアを組み合わせたキットにより最高の精度を実現 • デュプレックス法によりQ30以上の精度を実現 • 収量、速度、マルチプレックスなどの点で最適なソリューションUnderstanding the drivers of oncogenesis
This case study highlights how a wide range of tumour-specific variation that can be captured within a single nanopore sequencing assay — from complex structural variants to epigenetic modifications.Oxford Nanopore technology update
Hear about the latest technology performance and innovations in the pipeline.Accelerating cancer research through comprehensive genomic analysis
Learn how nanopore technology can accurately resolve complex structural variants to provide new insight into the mechanisms of health and disease.Oxford Nanopore at ASHG 2023
Join us for on-booth product demonstrations, Data for Breakfast, and our Industry Education Session which will showcase how nanopore technology can resolve even the most complex genetic variation.Workflow: Tumour-normal
Here we present an end-to-end workflow to detect somatic variation between tumour-normal paired research samples.NCM 2023 Houston: buy 3 tickets, get 1 free
If you're looking to attend the Nanopore Community Meeting with colleagues you can now purchase three tickets and get one ticket free.- “This was almost a year of clinical testing, and it took about 24 hours to figure this out in our lab.”Danny Miller(米国のワシントン大学)
Accelerating cancer research through comprehensive genomic analysis
Discover the unique attributes of nanopore sequencing that are enabling researchers to characterise cancer at unprecedented resolution, unlocking previously hidden variation and accelerating research.- “…structural variant calls were highly accurate and complete, showing improvement over the current short-read and long-read methods.”Mikhail Kolmogorov et al., NIH
99%以上のリード単位精度を取得するQ20+ケミストリ
V14とR10.4.1ポアを組み合わせたキットにより最高の精度を実現 • デュプレックス法によりQ30以上の精度を実現 • 収量、速度、マルチプレックスなどの点で最適なソリューションUnderstanding the drivers of oncogenesis
This case study highlights how a wide range of tumour-specific variation that can be captured within a single nanopore sequencing assay — from complex structural variants to epigenetic modifications.Oxford Nanopore technology update
Hear about the latest technology performance and innovations in the pipeline.Accelerating cancer research through comprehensive genomic analysis
Learn how nanopore technology can accurately resolve complex structural variants to provide new insight into the mechanisms of health and disease.Oxford Nanopore at ASHG 2023
Join us for on-booth product demonstrations, Data for Breakfast, and our Industry Education Session which will showcase how nanopore technology can resolve even the most complex genetic variation.Workflow: Tumour-normal
Here we present an end-to-end workflow to detect somatic variation between tumour-normal paired research samples.NCM 2023 Houston: buy 3 tickets, get 1 free
If you're looking to attend the Nanopore Community Meeting with colleagues you can now purchase three tickets and get one ticket free.- “This was almost a year of clinical testing, and it took about 24 hours to figure this out in our lab.”Danny Miller(米国のワシントン大学)
Accelerating cancer research through comprehensive genomic analysis
Discover the unique attributes of nanopore sequencing that are enabling researchers to characterise cancer at unprecedented resolution, unlocking previously hidden variation and accelerating research.- “…structural variant calls were highly accurate and complete, showing improvement over the current short-read and long-read methods.”Mikhail Kolmogorov et al., NIH
Item 1 of 11
ナノポアシークエンスは研究者に以下を提供できる唯一の技術です。
ショートリードからウルトラロングリードまで、どんな長さのDNA/RNA断片でもシークエンス可能
ニーズに合わせてシークエンス収量を調整可能(最大14 Tb)
解析データをリアルタイムで取得
簡易かつ迅速なワークフローまたは自動ワークフロー
最新試薬やキットごとに装置を新しく買いなおす必要はありません
詳細な生物学的解析
SNP & INDEL
メチル化
構造変異
フェージング
アセンブリ
技術の用途
当社のプラットフォームは、ヒト、植物、動物、病原菌、環境に関わる生物学的疑問の探究に用いられることで、実社会の課題を解決しています。また、医療や食物の安全性などの「応用」領域での活用も増えています。
詳細